These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 32228887)

  • 1. NUDT21 suppresses the growth of small cell lung cancer by modulating GLS1 splicing.
    Gao CC; Xu QQ; Xiao FJ; Wang H; Wu CT; Wang LS
    Biochem Biophys Res Commun; 2020 May; 526(2):431-438. PubMed ID: 32228887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of cleavage factor Im 25 promotes the proliferation of lung cancer cells through alternative polyadenylation.
    Huang J; Weng T; Ko J; Chen NY; Xiang Y; Volcik K; Han L; Blackburn MR; Lu X
    Biochem Biophys Res Commun; 2018 Sep; 503(2):856-862. PubMed ID: 29928883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transforming growth factor β1 alters the 3'-UTR of mRNA to promote lung fibrosis.
    Ko J; Mills T; Huang J; Chen NY; Mertens TCJ; Collum SD; Lee G; Xiang Y; Han L; Zhou Y; Lee CG; Elias JA; Jyothula SSK; Rajagopal K; Karmouty-Quintana H; Blackburn MR
    J Biol Chem; 2019 Oct; 294(43):15781-15794. PubMed ID: 31488543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NUDT21 alters glioma migration through differential alternative polyadenylation of LAMC1.
    Jonnakuti VS; Ji P; Gao Y; Lin A; Chu Y; Elrod N; Huang KL; Li W; Yalamanchili HK; Wagner EJ
    J Neurooncol; 2023 Jul; 163(3):623-634. PubMed ID: 37389756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LINC00921 reduces lung cancer radiosensitivity by destabilizing NUDT21 and driving aberrant MED23 alternative polyadenylation.
    Zhang N; Liu X; Huang L; Zeng J; Ma C; Han L; Li W; Yu J; Yang M
    Cell Rep; 2023 Dec; 42(12):113479. PubMed ID: 37999979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NUDT21 negatively regulates PSMB2 and CXXC5 by alternative polyadenylation and contributes to hepatocellular carcinoma suppression.
    Tan S; Li H; Zhang W; Shao Y; Liu Y; Guan H; Wu J; Kang Y; Zhao J; Yu Q; Gu Y; Ding K; Zhang M; Qian W; Zhu Y; Cai H; Chen C; Lobie PE; Zhao X; Sun J; Zhu T
    Oncogene; 2018 Aug; 37(35):4887-4900. PubMed ID: 29780166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NUDT21 regulates 3'-UTR length and microRNA-mediated gene silencing in hepatocellular carcinoma.
    Sun M; Ding J; Li D; Yang G; Cheng Z; Zhu Q
    Cancer Lett; 2017 Dec; 410():158-168. PubMed ID: 28964783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NUDT21 knockdown inhibits proliferation and promotes apoptosis of pancreatic ductal adenocarcinoma through EIF2 signaling.
    Zheng YS; Chen ML; Lei WD; Zhu SL; You XQ; Liu Y
    Exp Cell Res; 2020 Oct; 395(2):112182. PubMed ID: 32707135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NUDT21 inhibits bladder cancer progression through ANXA2 and LIMK2 by alternative polyadenylation.
    Xiong M; Chen L; Zhou L; Ding Y; Kazobinka G; Chen Z; Hou T
    Theranostics; 2019; 9(24):7156-7167. PubMed ID: 31695759
    [No Abstract]   [Full Text] [Related]  

  • 10. Myc-induced glutaminolysis bypasses HIF-driven glycolysis in hypoxic small cell lung carcinoma cells.
    Munksgaard Thorén M; Vaapil M; Staaf J; Planck M; Johansson ME; Mohlin S; Påhlman S
    Oncotarget; 2017 Jul; 8(30):48983-48995. PubMed ID: 28430666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nudt21 regulates the alternative polyadenylation of Pak1 and is predictive in the prognosis of glioblastoma patients.
    Chu Y; Elrod N; Wang C; Li L; Chen T; Routh A; Xia Z; Li W; Wagner EJ; Ji P
    Oncogene; 2019 May; 38(21):4154-4168. PubMed ID: 30705404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of NUDT21 contributes to cervical cancer progression through alternative polyadenylation.
    Xing Y; Chen L; Gu H; Yang C; Zhao J; Chen Z; Xiong M; Kazobinka G; Liu Y; Hou T
    Oncogene; 2021 Mar; 40(11):2051-2064. PubMed ID: 33619322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nudt21 Controls Cell Fate by Connecting Alternative Polyadenylation to Chromatin Signaling.
    Brumbaugh J; Di Stefano B; Wang X; Borkent M; Forouzmand E; Clowers KJ; Ji F; Schwarz BA; Kalocsay M; Elledge SJ; Chen Y; Sadreyev RI; Gygi SP; Hu G; Shi Y; Hochedlinger K
    Cell; 2018 Jan; 172(1-2):106-120.e21. PubMed ID: 29249356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternative polyadenylation reprogramming of MORC2 induced by NUDT21 loss promotes KIRC carcinogenesis.
    Tan Y; Zheng T; Su Z; Chen M; Chen S; Zhang R; Wang R; Li K; Na N
    JCI Insight; 2023 Sep; 8(18):. PubMed ID: 37737260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CFIm25 regulates glutaminase alternative terminal exon definition to modulate miR-23 function.
    Masamha CP; Xia Z; Peart N; Collum S; Li W; Wagner EJ; Shyu AB
    RNA; 2016 Jun; 22(6):830-8. PubMed ID: 27095025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of p62/SQSTM1 sensitizes small-cell lung cancer cells to cisplatin-induced cytotoxicity by targeting NEDD9 expression.
    Xu L; Xu F; Kong Q; Yang T; Tan D; Zhang X; Li N; Zhao S; Zhao J; Li M
    Mol Carcinog; 2020 Aug; 59(8):967-979. PubMed ID: 32424979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-485-5p suppresses the proliferation, migration and invasion of small cell lung cancer cells by targeting flotillin-2.
    Gao F; Wu H; Wang R; Guo Y; Zhang Z; Wang T; Zhang G; Liu C; Liu J
    Bioengineered; 2019 Dec; 10(1):1-12. PubMed ID: 30836864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of the inwardly rectifying potassium channel Kir2.1 (KCNJ2) modulates multidrug resistance of small-cell lung cancer under the regulation of miR-7 and the Ras/MAPK pathway.
    Liu H; Huang J; Peng J; Wu X; Zhang Y; Zhu W; Guo L
    Mol Cancer; 2015 Mar; 14():59. PubMed ID: 25880778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-25 regulates small cell lung cancer cell development and cell cycle through cyclin E2.
    Zhao Z; Liu J; Wang C; Wang Y; Jiang Y; Guo M
    Int J Clin Exp Pathol; 2014; 7(11):7726-34. PubMed ID: 25550809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cleavage and polyadenylation specific factor 4 targets NF-κB/cyclooxygenase-2 signaling to promote lung cancer growth and progression.
    Yi C; Wang Y; Zhang C; Xuan Y; Zhao S; Liu T; Li W; Liao Y; Feng X; Hao J; Gao Y; Yu W; Chen Y; Zhang C; Guo W; Tang B; Deng W
    Cancer Lett; 2016 Oct; 381(1):1-13. PubMed ID: 27450326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.